Company Directory

Lexaria Bioscience develops innovative drug delivery platforms including DehydraTECH™ for the delivery of lipophilic molecules. It increases bio-absorption; reduces time of onset; and can reduce drug costs for orally administered bioactives.

View Full Profile

Lovelace Biomedical is a large, not-for-profit CRO with interests including respiratory, infectious diseases, gene therapy, neuroscience, alternative tobacco products and medical countermeasures. Respiratory expertise includes formulations for DPIs, MDIs and nebulisers.

View Full Profile

LTS is a pharmaceutical technology company that develops and manufactures drug delivery systems such as transdermal patches, oral thin films and microarray patches. Its systems are applied in more than 20 marketed products targeting multiple disease indications.

View Full Profile

The health business team at Lubrizol Life Science partners with customers to speed their innovative medical devices and pharma products to market. Its team provides high-quality polymers and excipients, along with state-of-the-art product design, development and manufacturing services.

View Full Profile

Lucideon is a development and commercialisation company focusing on materials technologies and processes for mutliple industries. It has an extensive pharma offering including formulation development, E&L, powder processing, and its own controlled release drug delivery technology, iCRT.

View Full Profile

Lux Research provides market intelligence, focusing on technology-driven innovation. Its areas of focus include materials, health, food & wellness, digital and energy. The materials and health areas include coverage of drug delivery related aspects.

View Full Profile

See what ondrugdelivery's readers and contributors think

Matt Kempton user photo
Matt Kempton
Snr Project Engineer
Corning Incorporated

I am extremely impressed with the comprehensive presentation of information and problem/solution points detailed ... Kudos to you for an extremely well written article with succinct and robust scientific body of knowledge.

Abby Lockwood Opus Strategy photo
Abby Lockwood
Plan Strategic

ONdrugDelivery Magazine is a great resource that brings a lot of value to the work my team and I are doing in the area of drug delivery. The device-specific content as well as the broader discussions surrounding industry trends and issues are extremely informative and very well written.

Li-Chun Tsou, PhD, MBA
Principal Engineer
Merck & Co

Your website and publication is a great asset for me. I’d recommend your publication to my colleagues. I am sure that we will gain knowledge and update information through your timely report. Thanks for making it available.

Dr Cristian Vilos

I‘m working on the development of microparticles for the release of veterinary antibiotics, and polymeric nanoparticles for siRNA and chemotherapeutic delivery. ONdrugDelivery has been a very usefull platform to connect the scientific research, and marketed drug development.


W3 Total Cache is currently running in Pro version Development mode.